CSL ASX: Why fundies still love the biotech and BHP, NAB, CBA, Resmed, Macquarie, Goodman, Aristocrat stocks

  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 90%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Despite the headwinds, CSL is the most loved among high-performing stock pickers. CBA and BHP are also widely held – but not as widely as expected.

Already a subscriber?Two biotech developers, a gaming giant and a data centre provider are among the top stock picks of Australia’s best performing fund managers.

“CSL has been a great compounder over many, many years,” said hedge fund manager Jun Bei Liu, who holds the stock in the Tribeca Alpha Plus fund that she manages. “You find it in the bottom drawer of so many investment portfolios because it seems to grow year in, year out ... and has so many of the characteristics of a quality company.

CSL is still down more than 2 per cent this year but Sam Byrnes, a partner at ECP Asset Management, is among those still backing the company.“While CSL has encountered challenges ... we maintain an optimistic outlook on Behring’s long-term margin potential, and its competitive position in the flu business,” he said.

A recent investor survey by JPMorgan found that ResMed was the stock in the ASX 20 that was “most loved” by fund managers. Hyperion Australian Growth Companies, Airlie’s Australian Share Fund and Ellerston are among those owning significant positions in the stock.Aristocrat Leisure is the only company outside the 20 largest to be among the most held by stock pickers, including DNR Capital’s High Conviction Strategy and Macquarie’s Australian Shares Fund.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 2. in JP

日本 最新ニュース, 日本 見出し